Neuroendocrine Cancer | Tumor

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs

February 1st 2023, 8:00pm

Article

A new standard of care for advanced pancreatic neuroendocrine tumors demonstrates improvements in survival and tumor shrinkage.

Iadademstat-Placebo Combo to Be Studied in Neuroendocrine Cancers

January 26th 2023, 10:00pm

Article

Researchers just launched a phase 2 trial evaluating iadademstat plus paclitaxel in patients with relapsed/refractory neuroendocrine cancer, including those with small cell lung cancer.

Study Shows Preference for Quality of Life Over Quantity in Patients With Neuroendocrine Tumors

December 29th 2022, 2:00pm

Article

Maintaining independence was found to the be the most common health care goal in patients with stage 4 neuroendocrine tumors, a recent survey found.

Writing a Book Helped a Survivor Process Fears of Cancer Recurrence

November 10th 2022, 4:00pm

Podcast

A woman with a rare and aggressive cancer shares how writing about the realities of cancer survivorship improved her mental health and even helped strengthen her relationship with her family.

FDA OKs Clinical Trial for Novel Neuroendocrine Carcinoma Drug

November 10th 2022, 2:00pm

Article

A phase 2 clinical trial will evaluate iadademstat for patients with relapsed or refractory high-grade neuroendocrine carcinoma.

Clinical Trial Kicks Off Evaluating a New Drug for a Group of Solid Cancers

November 4th 2022, 7:00pm

Article

A novel drug, MRT-2359, will be studied in a phase 1/2 trial for patients with MYC-driven cancers.

FDA to Fast Track Development, Review of Novel Radiotherapy Drug for Neuroendocrine Tumors

October 28th 2022, 9:00pm

Article

The Food and Drug Administration will fast track the development and review of ITM-11 for the treatment of gastroenteropancreatic neuroendocrine tumors.

Do You Ever Question Your Cancer Care?

May 23rd 2022, 5:00pm

Article

I’ve always received impeccable care at my cancer center, but a recent experience made me feel like I was no longer a priority.

During the Pre-Cancer Days, My Intuition Pushed Me in the Right Direction

April 27th 2022, 5:00pm

Article

Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022, 3:02pm

Article

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.